1. Home
  2. EHTH vs MCRB Comparison

EHTH vs MCRB Comparison

Compare EHTH & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EHTH
  • MCRB
  • Stock Information
  • Founded
  • EHTH 1997
  • MCRB 2010
  • Country
  • EHTH United States
  • MCRB United States
  • Employees
  • EHTH N/A
  • MCRB N/A
  • Industry
  • EHTH Specialty Insurers
  • MCRB Biotechnology: Pharmaceutical Preparations
  • Sector
  • EHTH Finance
  • MCRB Health Care
  • Exchange
  • EHTH Nasdaq
  • MCRB Nasdaq
  • Market Cap
  • EHTH 176.1M
  • MCRB 141.9M
  • IPO Year
  • EHTH 2006
  • MCRB 2015
  • Fundamental
  • Price
  • EHTH $5.92
  • MCRB $0.37
  • Analyst Decision
  • EHTH Buy
  • MCRB Hold
  • Analyst Count
  • EHTH 4
  • MCRB 5
  • Target Price
  • EHTH $6.38
  • MCRB $4.00
  • AVG Volume (30 Days)
  • EHTH 188.3K
  • MCRB 1.3M
  • Earning Date
  • EHTH 05-06-2025
  • MCRB 05-07-2025
  • Dividend Yield
  • EHTH N/A
  • MCRB N/A
  • EPS Growth
  • EHTH N/A
  • MCRB N/A
  • EPS
  • EHTH N/A
  • MCRB 0.00
  • Revenue
  • EHTH $532,409,999.00
  • MCRB N/A
  • Revenue This Year
  • EHTH $1.38
  • MCRB N/A
  • Revenue Next Year
  • EHTH $8.81
  • MCRB N/A
  • P/E Ratio
  • EHTH N/A
  • MCRB $474.36
  • Revenue Growth
  • EHTH 17.56
  • MCRB N/A
  • 52 Week Low
  • EHTH $3.58
  • MCRB $0.46
  • 52 Week High
  • EHTH $11.36
  • MCRB $1.53
  • Technical
  • Relative Strength Index (RSI)
  • EHTH 34.05
  • MCRB 28.34
  • Support Level
  • EHTH $5.69
  • MCRB $0.36
  • Resistance Level
  • EHTH $6.24
  • MCRB $0.67
  • Average True Range (ATR)
  • EHTH 0.41
  • MCRB 0.07
  • MACD
  • EHTH 0.06
  • MCRB -0.02
  • Stochastic Oscillator
  • EHTH 40.41
  • MCRB 2.71

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: